Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs

Author(s):  Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P

Issue:  May/Jun 2002 - Health, Wellness, Geriatrics
View All Articles in Issue

Abstract:  The physical compatibility of Precedex with 95 selected other drugs during simulated Y-site injection was evaluated by visual observation, turbidity measurement, and electronic particle content assessment (when appropriate).

Five-milliliter samples of Precedex 4 µg/mL in 0.9% sodium chloride injection were combined with 5 mL of each of 95 other drugs. The other test drugs included antiinfectives, analgesics, antihistamines, diuretics, steroids, and other supportive-care drugs undiluted or diluted in 0.9% sodium chloride injection or 5% dextrose injection (for amphotericin B). Visual examinations were performed with the unaided eye in normal diffuse fluorescent light and with a Tyndall beam (a high-intensity monodirectional light beam) to enhance the visualization of small particles and low-level turbidity. The turbidity of each sample was measured as well, as was the particle content of samples with no visible incompatibility. Evaluation of the samples was performed initially and at 1 and 4 hours after preparation.

Ninety-three of the 95 test drugs were compatible with the Precedex dilution during the 4-hour observation period; however, both amphotericin B and diazepam resulted in precipitation. Precedex, which is incompatible with amphotericin B and diazepam, should not be administered simultaneously with those drugs.

Related Keywords: Precedex, compatibility of, Precedex, Y-site administration with other drugs

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P May/Jun 2002 230-233 Buy
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher Jul/Aug 2002 311-315 Buy
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Williams Kimberly Y, Baker Ma Jan/Feb 2001 69-72 Buy
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A May/Jun 2008 276-278 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A Mar/Apr 2008 156-160 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A Mar/Apr 2008 170-173 Buy
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Trusley Craig, Kupiec Thomas C, Trissel Lawrence A May/Jun 2006 230-233 Buy
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE Jul/Aug 2016 328-332 Buy
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A Nov/Dec 2007 520-524 Buy
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel Jan/Feb 2009 78-80 Buy